178 related articles for article (PubMed ID: 19463055)
1. Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk.
Osimitz TG; Lake BG
Crit Rev Toxicol; 2009; 39(6):501-11. PubMed ID: 19463055
[TBL] [Abstract][Full Text] [Related]
2. Mode of action in relevance of rodent liver tumors to human cancer risk.
Holsapple MP; Pitot HC; Cohen SM; Boobis AR; Klaunig JE; Pastoor T; Dellarco VL; Dragan YP
Toxicol Sci; 2006 Jan; 89(1):51-6. PubMed ID: 16221960
[TBL] [Abstract][Full Text] [Related]
3. Effect of Pyrethrins on cytochrome P450 forms in cultured rat and human hepatocytes.
Price RJ; Giddings AM; Scott MP; Walters DG; Capen CC; Osimitz TG; Lake BG
Toxicology; 2008 Jan; 243(1-2):84-95. PubMed ID: 18022748
[TBL] [Abstract][Full Text] [Related]
4. Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action.
Dellarco VL; McGregor D; Berry SC; Cohen SM; Boobis AR
Crit Rev Toxicol; 2006; 36(10):793-801. PubMed ID: 17118729
[TBL] [Abstract][Full Text] [Related]
5. A mode of action for induction of liver tumors by Pyrethrins in the rat.
Price RJ; Walters DG; Finch JM; Gabriel KL; Capen CC; Osimitz TG; Lake BG
Toxicol Appl Pharmacol; 2007 Jan; 218(2):186-95. PubMed ID: 17188729
[TBL] [Abstract][Full Text] [Related]
6. Human relevance framework for rodent liver tumors induced by the insecticide sulfoxaflor.
LeBaron MJ; Gollapudi BB; Terry C; Billington R; Rasoulpour RJ
Crit Rev Toxicol; 2014 May; 44 Suppl 2():15-24. PubMed ID: 24832551
[TBL] [Abstract][Full Text] [Related]
7. A mode of action for induction of thyroid gland tumors by Pyrethrins in the rat.
Finch JM; Osimitz TG; Gabriel KL; Martin T; Henderson WJ; Capen CC; Butler WH; Lake BG
Toxicol Appl Pharmacol; 2006 Aug; 214(3):253-62. PubMed ID: 16626768
[TBL] [Abstract][Full Text] [Related]
8. Case study: weight of evidence evaluation of the human health relevance of thiamethoxam-related mouse liver tumors.
Pastoor T; Rose P; Lloyd S; Peffer R; Green T
Toxicol Sci; 2005 Jul; 86(1):56-60. PubMed ID: 15716475
[TBL] [Abstract][Full Text] [Related]
9. Formaldehyde and glutaraldehyde and nasal cytotoxicity: case study within the context of the 2006 IPCS Human Framework for the Analysis of a cancer mode of action for humans.
McGregor D; Bolt H; Cogliano V; Richter-Reichhelm HB
Crit Rev Toxicol; 2006; 36(10):821-35. PubMed ID: 17118731
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
Preston RJ
Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
[TBL] [Abstract][Full Text] [Related]
11. Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator.
Elcombe CR; Peffer RC; Wolf DC; Bailey J; Bars R; Bell D; Cattley RC; Ferguson SS; Geter D; Goetz A; Goodman JI; Hester S; Jacobs A; Omiecinski CJ; Schoeny R; Xie W; Lake BG
Crit Rev Toxicol; 2014 Jan; 44(1):64-82. PubMed ID: 24180433
[TBL] [Abstract][Full Text] [Related]
12. Rodent carcinogenicity of peroxisome proliferators and issues on human relevance.
Lai DY
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2004 May; 22(1):37-55. PubMed ID: 15845221
[TBL] [Abstract][Full Text] [Related]
13. Mode of action analysis for pesticide-induced rodent liver tumours involving activation of the constitutive androstane receptor: relevance to human cancer risk.
Lake BG; Price RJ; Osimitz TG
Pest Manag Sci; 2015 Jun; 71(6):829-34. PubMed ID: 25045103
[TBL] [Abstract][Full Text] [Related]
14. Chloroform mode of action: implications for cancer risk assessment.
Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the human relevance of the constitutive androstane receptor-mediated mode of action for rat hepatocellular tumor formation by the synthetic pyrethroid momfluorothrin.
Okuda Y; Kushida M; Kikumoto H; Nakamura Y; Higuchi H; Kawamura S; Cohen SM; Lake BG; Yamada T
J Toxicol Sci; 2017; 42(6):773-788. PubMed ID: 29142176
[TBL] [Abstract][Full Text] [Related]
16. Development of a quantitative model incorporating key events in a hepatotoxic mode of action to predict tumor incidence.
Luke NS; Sams R; DeVito MJ; Conolly RB; El-Masri HA
Toxicol Sci; 2010 May; 115(1):253-66. PubMed ID: 20106946
[TBL] [Abstract][Full Text] [Related]
17. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
[TBL] [Abstract][Full Text] [Related]
18. PPARalpha agonist-induced rodent tumors: modes of action and human relevance.
Klaunig JE; Babich MA; Baetcke KP; Cook JC; Corton JC; David RM; DeLuca JG; Lai DY; McKee RH; Peters JM; Roberts RA; Fenner-Crisp PA
Crit Rev Toxicol; 2003; 33(6):655-780. PubMed ID: 14727734
[TBL] [Abstract][Full Text] [Related]
19. Editor's Highlight: Mode of Action Analysis for Rat Hepatocellular Tumors Produced by the Synthetic Pyrethroid Momfluorothrin: Evidence for Activation of the Constitutive Androstane Receptor and Mitogenicity in Rat Hepatocytes.
Okuda Y; Kushida M; Sumida K; Nagahori H; Nakamura Y; Higuchi H; Kawamura S; Lake BG; Cohen SM; Yamada T
Toxicol Sci; 2017 Aug; 158(2):412-430. PubMed ID: 28520973
[TBL] [Abstract][Full Text] [Related]
20. Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation.
Lake BG
Xenobiotica; 2009 Aug; 39(8):582-96. PubMed ID: 19622001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
